We are live on
!
Find out more
BCM
Blume Capital Management Portfolio holdings
AUM
$684M
1-Year Est. Return
41.68%
This Fund
S&P 500
This Quarter
Est. Return
+4.04%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$183M
AUM Growth
+$3.53M
(+2%)
Cap. Flow
-$2.05M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
43.27%
Holding
232
New
9
Increased
24
Reduced
46
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$3.03M |
| 2 |
Goldman Sachs
GS
|
+$1.64M |
| 3 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$906K |
| 4 |
Comcast
CMCSA
|
+$574K |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$466K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$3.38M |
| 2 |
AGN
Allergan plc
AGN
|
+$1.6M |
| 3 |
Range Resources
RRC
|
+$1.3M |
| 4 |
SLB Ltd
SLB
|
+$460K |
| 5 |
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
|
+$314K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.53% |
| 2 | Energy | 14.97% |
| 3 | Financials | 14.94% |
| 4 | Healthcare | 11.14% |
| 5 | Communication Services | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.54T
| $13.8M | 7.54% |
298,680
-3,100
| -1% | -$141K |
|
2
Devon Energy
DVN
$52.1B
| $7.62M | 4.16% |
173,437
+1,825
| +1% | +$70.7K |
|
3
iShares Biotechnology ETF
IBB
$9.34B
| $7.46M | 4.07% |
67,976
-1,150
| -2% | -$123K |
|
4
Microsoft
MSFT
$3.45T
| $7.46M | 4.07% |
75,638
-2,165
| -3% | -$210K |
|
|
5
SLB Ltd
SLB
$73.6B
| $7.44M | 4.06% |
110,958
-6,703
| -6% | -$460K |
|
6
Johnson & Johnson
JNJ
$618B
| $7.34M | 4% |
60,473
+830
| +1% | +$104K |
|
|
7
Comcast
CMCSA
$85B
| $7.24M | 3.95% |
220,728
+17,605
| +9% | +$574K |
|
8
Oracle
ORCL
$374B
| $7.24M | 3.95% |
164,300
-575
| -0.3% | -$26.5K |
|
9
Alphabet (Google) Class C
GOOG
$4.36T
| $6.86M | 3.74% |
122,960
| – | – |
|
10
Wells Fargo
WFC
$261B
| $6.83M | 3.73% |
123,235
+2,606
| +2% | +$140K |
|
|
AGN
11
DELISTED
Allergan plc
AGN
| $6.78M | 3.7% |
40,661
-9,986
| -20% | -$1.6M |
|
12
MetLife
MET
$61.9B
| $5.61M | 3.06% |
128,576
+900
| +0.7% | +$42K |
|
13
Capital One
COF
$128B
| $5.29M | 2.89% |
57,550
+1,125
| +2% | +$106K |
|
|
OAK
14
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $5.28M | 2.88% |
129,950
-7,750
| -6% | -$314K |
|
|
15
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
| $4.58M | 2.5% |
184,070
+36,470
| +25% | +$906K |
|
16
General Motors
GM
$80.4B
| $4.45M | 2.43% |
112,876
-2,425
| -2% | -$95.5K |
|
17
Weyerhaeuser
WY
$18B
| $4.43M | 2.42% |
121,550
+1,980
| +2% | +$72.4K |
|
18
Walt Disney
DIS
$167B
| $4.22M | 2.3% |
40,264
-340
| -0.8% | -$34.8K |
|
19
Intel
INTC
$455B
| $4.1M | 2.23% |
82,415
-950
| -1% | -$50.4K |
|
20
Qualcomm
QCOM
$155B
| $4.02M | 2.19% |
71,640
-4,400
| -6% | -$246K |
|
21
GE Aerospace
GE
$374B
| $3.74M | 2.04% |
57,301
-4,633
| -7% | -$309K |
|
22
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $3.6M | 1.96% |
25,647
| – | – |
|
23
Kinder Morgan
KMI
$71.7B
| $3.52M | 1.92% |
199,505
-5,300
| -3% | -$86.7K |
|
24
Halliburton
HAL
$26.9B
| $3.37M | 1.84% |
74,875
-500
| -0.7% | -$24.9K |
|
25
JPMorgan Chase
JPM
$935B
| $3.09M | 1.69% |
29,661
-700
| -2% | -$76.8K |
|
Similar funds
HCP
TWM
HWM
ECM
DMC
NS
CIA
CCG
Blume Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Blume Capital Management held 232 positions worth $183M, up 2% from $180M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Blume Capital Management's Q2 2018 filing shows 9 new, 24 increased, 46 reduced and 37 closed positions. Its largest new stake was CVS Health: 46,045 shares worth $2.96M. The largest sale was TJX Companies, an estimated $3.38M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Energy and Financials.
- Blume Capital Management's largest Q2 2018 buy was CVS Health: 46,045 shares worth $2.96M.
- Blume Capital Management added most to Goldman Sachs in Q2 2018, an estimated $1.64M increase.
- Blume Capital Management's biggest Q2 2018 reduction was TJX Companies, cutting an estimated $3.38M.
- Blume Capital Management fully exited Range Resources in Q2 2018, selling an estimated $1.3M.
- Blume Capital Management's ten largest holdings make up 43% of its $183M portfolio in Q2 2018.
- Blume Capital Management opened 9 new positions and closed 37 in Q2 2018.
- Blume Capital Management's portfolio value rose 2% quarter-over-quarter to $183M.
Based on Blume Capital Management's 13F filing for Q2 2018, filed 2 Aug 2018.